User:Elizabeth Perkins: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
== Knight Cancer Institute Seminar Series == | |||
*Charles Keller, MD Pediatric Cancer Biology Program | *Charles Keller, MD Pediatric Cancer Biology Program | ||
*c/o Elizabeth Perkins, Administrative Coordinator | *c/o Elizabeth Perkins, Administrative Coordinator | ||
Line 25: | Line 25: | ||
==Schedule== | ==Schedule== | ||
11/02/2010 | *11/02/2010 - Martin McMahon, PhD | ||
Martin McMahon, PhD | |||
"Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy" | "Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy" | ||
*11/30/2010 - Robert S. Krauss, PhD | |||
11/30/2010 | |||
Robert S. Krauss, PhD | |||
"Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors" | "Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors" | ||
12/02/2010 | *12/02/2010 - Shaomeng Wang, PhD | ||
Shaomeng Wang, PhD | |||
Vollum Aditorium | Vollum Aditorium | ||
Line 47: | Line 42: | ||
12/14/2010 | *12/14/2010 - Edward E. Schmidt, PhD | ||
Edward E. Schmidt, PhD | |||
"Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice" | "Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice" | ||
1/18/2011 | *1/18/2011 - Brian Rubin,MD, PhD | ||
Brian Rubin,MD, PhD | |||
TBD | TBD | ||
2/15/2011 | *2/15/2011 - John R. Ohlfest, PhD | ||
John R. Ohlfest, PhD | |||
TBD | TBD | ||
3/08/2011 | *3/08/2011 - Amy Wagers,PhD | ||
Amy Wagers,PhD | |||
TBD | TBD | ||
3/29/2011 | *3/29/2011 - William Stratford May | ||
William Stratford May | |||
TBD | TBD | ||
4/12/2011 | *4/12/2011 - David Bentley, PhD | ||
David Bentley, PhD | |||
TBD | TBD | ||
*6/14/2011 - James Ford,MD | |||
6/14/2011 | |||
James Ford,MD |
Revision as of 15:48, 26 October 2010
Knight Cancer Institute Seminar Series
- Charles Keller, MD Pediatric Cancer Biology Program
- c/o Elizabeth Perkins, Administrative Coordinator
- Oregon Health & Science University
- Pape'Family Pediatric Research Institute
- Mail Code: L321
- 3181 SW Sam Jackson Park Road
- Portland, OR 97239
- 503-494-9962
- perkinel@ohsu.edu
Objectives of the Knight Cancer Institute Seminar Series
The first annual Knight Cancer Institute Seminar series, co-sponsored by the Pediatric Cancer Biology program and the Knight Cancer Institute, will have a strong presence of childhood cancer basic and translational research topics presented by leading extramural scientists.
Knight Cancer Institute Seminar Series 2010-2011
- OHSU Main Hospital 8th Floor Conference Room 8B60
Tuesdays 4:00pm - 5:00pm
- Coordinator contact information: perkinel@ohsu.edu
Schedule
- 11/02/2010 - Martin McMahon, PhD
"Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy"
- 11/30/2010 - Robert S. Krauss, PhD
"Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors"
- 12/02/2010 - Shaomeng Wang, PhD
Vollum Aditorium
"Targeting Protein-Protein Interactions in the Apoptosis Pathwasys for New Cancer Therapeutics"
- 12/14/2010 - Edward E. Schmidt, PhD
"Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice"
- 1/18/2011 - Brian Rubin,MD, PhD
TBD
- 2/15/2011 - John R. Ohlfest, PhD
TBD
- 3/08/2011 - Amy Wagers,PhD
TBD
- 3/29/2011 - William Stratford May
TBD
- 4/12/2011 - David Bentley, PhD
TBD
- 6/14/2011 - James Ford,MD